Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.27 USD
Change Today +0.07 / 3.18%
Volume 443.3K
As of 2:03 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

amarin corp plc -adr (AMRN) Snapshot

Open
$2.22
Previous Close
$2.20
Day High
$2.30
Day Low
$2.18
52 Week High
03/16/15 - $3.33
52 Week Low
11/11/14 - $0.78
Market Cap
416.3M
Average Volume 10 Days
872.9K
EPS TTM
$-0.32
Shares Outstanding
183.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMARIN CORP PLC -ADR (AMRN)

amarin corp plc -adr (AMRN) Related Businessweek News

No Related Businessweek News Found

amarin corp plc -adr (AMRN) Details

Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

201 Employees
Last Reported Date: 03/3/15
Founded in 1989

amarin corp plc -adr (AMRN) Top Compensated Officers

Chief Executive Officer, President, Assistant...
Total Annual Compensation: $500.0K
Principal Financial Officer, Principal Accoun...
Total Annual Compensation: $212.5K
Senior Vice President and President of Resear...
Total Annual Compensation: $404.8K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $400.9K
Compensation as of Fiscal Year 2014.

amarin corp plc -adr (AMRN) Key Developments

Amarin Corporation plc Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 08:00 AM

Amarin Corporation plc Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 08:00 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: John F. Thero, Chief Executive Officer, President, Assistant Secretary and Director.

Amarin Corporation plc Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Amarin Corporation plc reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's total revenues were $15,933,000 against $10,967,000 a year ago. Operating loss was $27,049,000 compared to $25,571,000 a year ago. Loss from operations before taxes was $31,598,000 compared to $25,555,000 a year ago. Net loss was $31,126,000 or $0.18 per basic and diluted share compared to $25,980,000 or $0.15 per diluted share a year ago. Adjusted net loss for EPS - non GAAP was $28,557,000 or $0.16 per basic and diluted share compared to $28,488,000 or $0.16 per basic and diluted share a year ago. Net cash outflows from operation, excluding the $15 million in proceeds from the upfront licensing fee, were $27.6 million in the first quarter of 2015 as compared with $27.5 million in the first quarter of 2014.

Amarin Corporation plc to Report Q1, 2015 Results on May 08, 2015

Amarin Corporation plc announced that they will report Q1, 2015 results at 8:00 AM, Eastern Standard Time on May 08, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $2.27 USD +0.07

AMRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $70.25 USD +2.72
Enzymotec Ltd $8.11 USD -0.40
Incyte Corp $104.95 USD +1.99
Jazz Pharmaceuticals PLC $193.56 USD +3.18
Momenta Pharmaceuticals Inc $21.68 USD -0.07
View Industry Companies
 

Industry Analysis

AMRN

Industry Average

Valuation AMRN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit www.amarincorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.